Near misses of ACR/EULAR criteria for remission: Effects of patient global assessment in Boolean and index-based definitions

Annals of the Rheumatic Diseases

Volumn 71, Issue 10, 2012, Pages 1702-1705

  Studenic, Paul ^a   Smolen, Josef S ^a,b   Aletaha, Daniel ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hietzing Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR;

ACR EULAR CRITERIA; ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CRITERION VARIABLE; DISEASE CLASSIFICATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFORMATION SCIENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORNING STIFFNESS; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PATIENT GLOBAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REMISSION; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; VISUAL ANALOG SCALE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIAGNOSTIC SELF EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; REMISSION INDUCTION;

EID: 84866108933     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201519     Document Type: Article

References (20)

1. Sokka T, Hetland ML, Mäkinen H, et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642-51.
2. Felson DT, Smolen JS, Wells G, et al. American College of Rheumatology/European League against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis 2011;70:404-13.
3. Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
4. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993;20:555-6.
5. Kirwan JR, Newman S, Tugwell PS, et al. Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9. J Rheumatol 2009;36:2071-6.
6. Kalyoncu U, Dougados M, Daures JP, et al. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009;68:183-90.
7. Vermeer M, Kuper H, van der Biijl A, et al. The new ACR/EULAR definition of remission in rheumatoid arthritis: is the patient global assessment criterion too strict? [abstract]. Ann Rheum Dis 2011;70(Suppl 3):178.
8. Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses. Rheumatology (Oxford) 2002;41:1367-74.
9. Kapral T, Dernoschnig F, Machold KP, et al. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Arthritis Res Ther 2007;9:R72.
10. Kirwan JR, Tugwell PS. Overview of the patient perspective at OMERACT 10 - conceptualizing methods for developing patient-reported outcomes. J Rheumatol 2011;38:1699-701.
11. Tugwell PS, Petersson IF, Boers M, et al. Domains selection for patient-reported outcomes: current activities and options for future methods. J Rheumatol 2011;38:1702-10.
12. Khan NA, Spencer HJ, Abda E, et al. Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken) 2012;64:206-14.
13. Nicolau G, Yogui MM, Vallochi TL, et al. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol 2004;31:1293-6.
14. Studenic P, Radner H, Smolen J, et al. Discrepancies between patients and physicians in the perception of rheumatoid arthritis disease activity. Arthritis Rheum In Press.
15. Bombardier C, Tugwell P. A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol 1982;9:753-7.
16. Goldsmith CH, Smythe HA, Helewa A. Interpretation and power of a pooled index. J Rheumatol 1993;20:575-8.
17. Heiberg T, Finset A, Uhlig T, et al. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:191-5.
18. Fitzcharles M.-A., Almahrezi A, Shir Y. Pain: Understanding and challenges for the rheumatologist. Arthritis Rheum 2005;52:3685-92.
19. Khan NA, Spencer HJ, Abda EA, et al. Patient 's global assessment of disease activity and patient 's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent? Ann Rheum Dis. Published Online First: 24 April 2012. doi: 10.1136/annrheumdis-2011-201142
20. Barton JL, Imboden J, Graf J, et al. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010;62:857-64.